Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources

This beaten-down stock has suddenly found new life, but not for the right reason.

Over the past six months, Amneal’s shares (currently trading at $7.97) have posted a disappointing 8.7% loss, well below the S&P 500’s 5.4% gain. This may have investors wondering how to approach the situation.

Vertex Pharmaceuticals trades at $469.50 and has moved in lockstep with the market. Its shares have returned 6.5% over the last six months while the S&P 500 has gained 5.4%.

Shareholders of Freshpet would probably like to forget the past six months even happened. The stock dropped 54.8% and now trades at $72.17. This may have investors wondering how to approach the situation.

Over the past six months, American Financial Group’s shares (currently trading at $126.21) have posted a disappointing 7.9% loss, well below the S&P 500’s 5.4% gain. This was partly due to its softer quarterly results and might have investors contemplatin

Over the past six months, Astec has been a great trade, beating the S&P 500 by 9.1%. Its stock price has climbed to $40.02, representing a healthy 14.5% increase. This was partly thanks to its solid quarterly results, and the performance may have investor

Griffon has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7% to $82.50 per share while the index has gained 5.4%.

Since July 2020, the S&P 500 has delivered a total return of 98.4%. But one standout stock has more than doubled the market - over the past five years, Blue Bird has surged 261% to $46.50 per share. Its momentum hasn’t stopped as it’s also gained 22.1% in

Revolve’s stock price has taken a beating over the past six months, shedding 29.6% of its value and falling to $21.98 per share. This may have investors wondering how to approach the situation.

Over the past six months, Dentsply Sirona’s stock price fell to $16.13. Shareholders have lost 17.8% of their capital, which is disappointing considering the S&P 500 has climbed by 5.4%. This might have investors contemplating their next move.

Driven Brands currently trades at $17.10 per share and has shown little upside over the past six months, posting a middling return of 2.8%.

(Bloomberg) -- It was the buzziest bond trade in London’s financial circles — a good chance at a quick profit, and all the gains coming tax free.Most Read from BloombergThe High Costs of Trump’s ‘Big Beautiful’ New Car Loan DeductionCan This Bridge Ease t

XRP's value has surged nearly 480% in just 12 months. XRP is priced for perfection, and it's looking increasingly like a speculative gamble. Cryptocurrency XRP (CRYPTO: XRP) has gained lots of attention from investors lately, resulting in a 480% increase

These energy stocks provide high-octane income streams.